An Open-Label Study of Two Formulations of LX1033 in Healthy Human Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
The purpose of this study is to assess the pharmacodynamic effects, pharmacokinetics, and safety of two oral formulations (tablet and capsule) of LX1033 in normal healthy volunteers.
Epistemonikos ID: ed5deac7382bd22db1fe0ba2cad5ab37a6a76aed
First added on: May 06, 2024